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Glucose-insulin system models can be used for improved glycemic control of critically ill patients. A key component of glucose-insulin models is pancreatic insulin secretion. There is limited data in the literature quantifying insulin secretion in critically ill patients at physiologic levels. This study presents a model pancreatic insulin secretion in critically ill patients based on data from a critically ill population. 

Methods: 
19 patients from the Christchurch Hospital ICU enrolled in a prospective clinical trial studying sepsis each had arterial blood samples assayed for insulin and C-peptide (Table 1). Two sets of four samples were taken from each patient, with each set collected over 60 minutes. Blood glucose (BG) data was collected with a bedside glucometer (Super-Glucocard II, Arkray Inc., Japan). 

C-peptide data was deconvolved using the model and population parameter values of van Cauter et al. [1] to determine pancreatic insulin secretion rates (ISR). Data from Kjems et al. [2] investigating the potentiating effects of glucagon-like-peptide-1 on insulin secretion, suggested a maximum secretion rate of 16 U/hr. A minimum rate of 1 U/hr was also adopted.

Results: 
The best model for insulin secretion was based on blood glucose concentration alone. There was clear separation of secretion levels between normal glucose tolerant (NGT) and impaired glucose tolerant (IGT) patients. Hence, ISR was modeled as a constrained linear function of BG (in mmol/L) for NGT and IGT patients separately with R2=0.61 and 0.69 respectively.

NGT:	 ISR = 893*BG - 2996, constrained to [1000 - 16000]   (mU/hr)
IGT:	 ISR = 296*BG - 1644, constrained to [1000 - 16000]   (mU/hr)

Figure 1 presents the data and models. There is considerable variability in secretion rates for any given blood glucose level, particularly in the range 6-10 mmol/l. The glucose coefficients of 893 and 296 mU.l/mmol.hr were comparable to data published in a number of other studies for healthy and diabetic subjects.

Conclusions: 
This work presents a simple model of pancreatic insulin secretion in critically ill patients based on clinical data. The model is a function of blood glucose level and glucose tolerance status and can be easily incorporated into glucose-insulin system models. 
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Figure 1: Endogenous insulin secretion rate data and model for normal glucose tolerant (NGT) and impaired glucose tolerant (IGT) patients.


